T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and renal cell carcinoma

DNA and Cell Biology

Volumn 31, Issue 7, 2012, Pages 1285-1289

  Cai, Chen ^a   Wang, Linhui ^a   Wu, Zhenjie ^a   Li, Minyu ^a   Chen, Wei ^a   Sun, Yinghao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3 GENE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863966362     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1625     Document Type: Article

References (19)

1. Arai, E., and Kanai, Y. (2010). Genetic and epigenetic alterations during renal carcinogenesis. Int J Clin Exp Pathol 4, 58-73.
2. Bruck, P., Ramos-Lopez, E., Bartsch, W., Bohme, A., and Badenhoop, K. (2008). Tim-3 polymorphisms in type 1 diabetes families. J Hum Genet 53, 559.
3. Cao, B., Zhu, L., Zhu, S., Li, D., Zhang, C., Xu, C., and Zhang, S. (2010). Genetic variations and haplotypes in tim-3 gene and the risk of gastric cancer. Cancer Immunol Immunother 59, 1851.
4. Chae, S.C., Park, Y.R., Lee, Y.C., Lee, J.H., and Chung, H.T. (2004a). The association of tim-3 gene polymorphism with atopic disease in Korean population. Hum Immunol 65, 1427-1431.
5. Chae, S.C., Park, Y.R., Shim, S.C., Yoon, K.S., and Chung, H.T. (2004b). The polymorphisms of Th1 cell surface gene tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 95, 91.
6. Chow, W.H., Dong, L.M., and Devesa, S.S. (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7, 245-257.
7. DeKruyff, R.H., Bu, X., Ballesteros, A., Santiago, C., Chim, Y.L., Lee, H.H., Karisola, P., Pichavant, M., Kaplan, G.G., Umetsu, D.T., Freeman, G.J., and Casasnovas, J.M. (2010). T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 184, 1918.
8. Geng, H., Zhang, G.M., Li, D., Zhang, H., Yuan, Y., Zhu, H.G., Xiao, H., Han, L.F., and Feng, Z.H. (2006). Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol 176, 1411-1420.
9. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M.J. (2009). Cancer statistics, 2009. CA Cancer J Clin 59, 225-249.
10. Kuchroo, V.K., Umetsu, D.T., DeKruyff, R.H., and Freeman, G.J. (2003) The tim gene family: Emerging roles in immunity and disease. Nat Rev Immunol 3, 454.
11. Lipworth, L., Tarone, R.E., and McLaughlin, J.K. (2006). The epidemiology of renal cell carcinoma. J Urol 176, 2353-2358.
12. Monney, L., Sabatos, C.A., Gaglia, J.L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E.A., Coyle, A.J., Sobel, R.A., Freeman, G.J., and Kuchroo, V.K. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536-541.
13. Nakayama, M., Akiba, H., Takeda, K., Kojima, Y., Hashiguchi, M., Azuma, M., Yagita, H., and Okumura, K. (2009). Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113, 3821.
14. Renesto, P.G., Ponciano, V.C., Cenedeze, M.A., Saraiva Câmara, N.O., and Pacheco Silva, A. (2007). High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 7, 1661-1665.
15. Sabatos, C.A., Chakravarti, S., Cha, E., Schubart, A., Sanchez-Fueyo, A., Zheng, X.X., Coyle, A.J., Strom, T.B., Freeman, G.J., and Kuchroo, V.K. (2003). Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4, 1102-1110.
16. Sanchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X.X., Sabatos, C.A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V.K., Gutierrez-Ramos, J.C., Coyle, A.J., and Strom, T.B. (2003). Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4, 1093-101.
17. Van De Weyer, P.S., Muehlfeit, M., Klose, C., Bonventre, J.V., Walz, G., and Kuehn, E.W. (2006). A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 351, 571-576.
18. Wang, Y., Meng, J., Wang, X., Liu, S., Shu, Q., Gao, L., Ju, Y., Zhang, L., Sun, W., and Ma, C. (2008). Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 67, 63-70.
19. Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., Zheng, X.X., Strom, T.B., and Kuchroo, V.K. (2005). The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6, 1245-1252.